GLP-1 patient guides
Step-by-step walkthroughs for real patient situations: insurance appeals, dose titration, side-effect management, travel logistics, and provider switching.
Reference
Complete GLP-1 Guide 2026 →
Comprehensive 4,800-word reference covering medications, providers, cost, side effects, dosing, and insurance navigation.
The GLP-1s That Were Quietly Discontinued — and What They Tell You About the Ones Left →
Byetta, Bydureon, and Victoza left the US market in 2024. Half the articles online still describe them in the present tense. Here's the accurate version.
Cost + insurance
Cheapest GLP-1 Provider 2026 →
12-provider price ranking with income-tier recommendations and cash-pay vs insurance pathways.
Compounded Semaglutide 2026 Buyer Guide →
FDA-aware honest buyer guide covering 503A regulation, PCAB verification, and risk assessment.
Compounded GLP-1 Post-FDA-Enforcement 2026 →
What changed after FDA declared shortage end (Oct 2024) — 503A scope, market dynamics, alternatives.
Five Things Almost Every Article About Medicare Drug Appeals Gets Wrong →
Primary-source corrections from 42 CFR Part 423: the 65-day myth, the 14-day payment track, the 24-hour auto-forward rule, prescriber standing, and the real dollar thresholds.
The GLP-1 Price Traps That Cost People the Most →
Copay cards barred on government plans, intro prices multiplied by twelve, the 45-day refill window worth ~$3,000/yr, and the compounded-vs-covered inversion.
What "Not FDA-Approved" Actually Means for Compounded GLP-1s →
The concrete consequences — including the two that flip the price comparison — plus the post-shortage rules and six questions to ask before buying.
TrumpRx and the $50 Medicare Bridge: Who Actually Qualifies in 2026 (and Who Doesn't) →
Two new 2026 GLP-1 pricing programs, both narrower than the headlines — exactly which drugs, which people, and which dates each covers.
The GLP-1 Savings-Card Fine Print Nobody Reads Until It Costs Them →
The $25 headline is real for one kind of patient. For everyone else the card means something different, expires on a date few check, and hides a text-message trap.
Compounded GLP-1s After the Shortage Ended: What Changed, and What's Legal Now →
The shortage that let pharmacies mass-compound GLP-1s is over. That changes the legal footing under your prescription — and the brand cash prices fell far enough to re-run the decision.
Does Insurance Cover GLP-1s for Weight Loss? The BMI Math and the Prior-Auth Reality →
"Covered" is not a yes/no answer for GLP-1s — it's a series of gates, and you can be denied at any one for reasons that have nothing to do with whether the drug would help you.
What a Month of GLP-1 Actually Costs in Mid-2026 — the Real Numbers, With the Traps →
The list price is fiction, the $199 is an introductory rate, and one manufacturer's "$449 maintenance" becomes $699 if you refill four days late. Here are the real numbers.
Getting started
How Long Does Wegovy Take to Work? →
Week-by-week expected outcomes from STEP-1 trial data: weight, appetite, side-effect timing.
Wegovy First-Month Survival Guide →
Practical playbook for surviving titration weeks 1-4: meal timing, hydration, side-effect management.
Switching from Ozempic to Wegovy 2026 →
When prescribers switch + transition timing + dose re-titration considerations.
The GLP-1 Questions You'll Have at 9pm With a Pen in Your Hand →
Storage windows by drug, the freezing rule with no judgment call, missed-dose decision flow, injection-site reactions, and sharps disposal.
How to Tell a Real GLP-1 Pen From a Counterfeit — Before You Inject It →
Counterfeit semaglutide is in the US supply chain and the fakes are good. You can't out-inspect a good fake — but you can out-verify one. Here's how.
Milligrams vs Units: The GLP-1 Dosing Mistake That Sends People to the ER →
When a GLP-1 comes as a vial and a syringe instead of a pre-set pen, the dosing arithmetic lands back in your hands — and it's where the FDA-reported overdoses happen.
Side effects
Wegovy Sulfur Burps — Causes + Management →
Why sulfur burps happen on Wegovy, when to worry, and evidence-based self-management strategies.
Ozempic Face — Prevention + Treatment →
Facial volume loss with rapid weight loss: prevention with protein + resistance training + dermatologist options.
GLP-1 Hair Loss + Protein Deficit 2026 →
Telogen effluvium from rapid weight loss: timeline, protein requirements, recovery, when to see dermatologist.
GLP-1 Side Effects: The Ones That Mean "Keep Going" vs the Ones That Mean "Call Someone Now" →
Most GLP-1 side effects are expected and settle after a dose increase. A few are not. Confusing the two makes people quit a drug that was working — or wait on a symptom they shouldn't.
Plateau + maintenance
Special populations
GLP-1 and Mental Health 2026 Evidence Review →
Mood/anxiety/suicidality signal monitoring + FDA review status + clinical recommendations.
GLP-1 + Mental Health Medications 2026 →
Drug-drug overlap with SSRIs/SNRIs/atypical antipsychotics — co-prescribing guidance.
Wegovy and Pregnancy 2026 →
2-month washout per FDA label, pregnancy registry, and fertility planning considerations.
GLP-1 for Adults 65+ 2026 →
Geriatric-specific considerations: sarcopenia risk, dose adjustments, fall prevention.
GLP-1 and Cancer History 2026 →
MTC + MEN2 contraindications, breast cancer considerations, and personal/family history assessment.
Drug interactions
Mixing GLP-1 with Insulin 2026 →
Hypoglycemia risk + insulin dose reduction protocols + monitoring frequency.
GLP-1 and Alcohol 2026 Evidence Review →
AUD craving reduction signal + safety + dose-response considerations.
GLP-1 Alcohol Tolerance Changes →
Why "1 drink hits like 3" — gastric emptying + food intake mechanisms + safety guidance.
Comparisons
Zepbound vs Mounjaro 2026 →
Same tirzepatide molecule, different FDA indications. When prescribers choose each.
Sleeve Gastrectomy vs GLP-1 2026 →
Bariatric surgery vs pharmacotherapy: efficacy, cost, durability, and patient suitability.
Two Molecules, Four Brands: The GLP-1 Map That Ends the Confusion →
Which GLP-1 comparisons are real, which have head-to-head trials, and why the brand — not the molecule — decides your cost.
Tirzepatide vs Semaglutide: What the Head-to-Head Trial Actually Showed →
The two drugs were finally compared in one randomized trial. The result was decisive on average — and still not a reason for everyone to switch.
Logistics
Wegovy and Travel 2026 →
TSA carry-on rules, refrigeration logistics, time-zone re-scheduling, and international tips.
Wegovy Travel: Refrigeration + TSA Deep-Dive →
Hard-logistics reference: exact temperature windows, cooler equipment ranking, customs by country.
Free Protein Guide for GLP-1 Patients →
1.2-1.6 g/kg lean mass protein protocols for preserving muscle during GLP-1-induced weight loss.
GLP-1 information library
Reference articles on how these medications work, dosing schedules, side effects, and how they interact with other conditions. Educational, sourced, not medical advice.